NIH Teaming Up With Pharma Giants For New Treatments

The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.

“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”

The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.

Tags: , , ,

About TRNS Washington Desk

View all posts by TRNS Washington Desk
News updates from on and around Capitol Hill.

No comments yet.

Leave a Reply

You must be logged in to post a comment.